Previously, we established a novel HSF1/PGC-1α axis activator screening system and identified the clinical hepatoprotective agent matrine as a robust HSF1/PGC-1α axis activator that efficiently alleviated obesity by inducing a thermogenic program in mice (Li et al., 2022a). Here, HSF1 is linked to obesity disorder.